Skip to Content

A319 (Fenofibrate (Micronized) 200 mg)

Pill with imprint A319 is Orange, Capsule-shape and has been identified as Fenofibrate (Micronized) 200 mg. It is supplied by Alembic Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A319

Fenofibrate (Micronized)

Imprint
A319
Strength
200 mg
Color
Orange
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0086

Get help with Imprint Code FAQs.

Related Images for "A319"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.